Literature DB >> 8612815

Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2.

U K Messmer1, D M Reimer, J C Reed, B Brüne.   

Abstract

Endogenously generated or exogenously supplied nitric oxide causes cleavage of poly(ADP-ribose) polymerase (PARP) and apoptotic cell death in RAW 264.7 macrophages. With the use of NO donors such as S-nitrosoglutathione or spermine-NO we established that PARP digestion occurs in parallel with DNA fragmentation, and is preceded by accumulation of the tumor suppressor gene product p53. PARP cleavage in response to lipopolysaccharide and interferon-gamma treatment is prevented by NG-monomethyl-L-arginine, thus proving a NO requirement. Endogenous NO generation, p53 accumulation, and PARP degradation occurred prior to the detection of significant chromatin condensation. In contrast, in stable Bcl-2 transfected cells, NO-initiated PARP cleavage was almost completely blocked. Our data implicate PARP as a proteolytic substrate during NO-mediated apoptotic cell death in RAW 264.7 macrophages and establish Bcl-2 as an efficient signal terminator in this process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612815     DOI: 10.1016/0014-5793(96)00311-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

1.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways.

Authors:  U K Messmer; B Brüne
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.

Authors:  J M Jürgensmeier; S Krajewski; R C Armstrong; G M Wilson; T Oltersdorf; L C Fritz; J C Reed; S Ottilie
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

4.  TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.

Authors:  W Lu; Y Wang; Q Zhang; S Owen; M Green; T Ni; M Edwards; Y Li; L Zhang; A Harris; J-L Li; D G Jackson; S Jiang
Journal:  Clin Exp Immunol       Date:  2019-07-03       Impact factor: 4.330

5.  Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages.

Authors:  S Hortelano; E López-Collazo; L Boscá
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 6.  Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP).

Authors:  Badar Ul Islam; Safia Habib; Parvez Ahmad; Shaziya Allarakha; Asif Ali
Journal:  Indian J Clin Biochem       Date:  2015-01-20

7.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

8.  NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages.

Authors:  A von Knethen; D Callsen; B Brüne
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

9.  Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor.

Authors:  S Cho; B T Volpe; Y Bae; O Hwang; H J Choi; J Gal; L C Park; C K Chu; J Du; T H Joh
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

10.  Arginase II inhibited lipopolysaccharide-induced cell death by regulation of iNOS and Bcl-2 family proteins in macrophages.

Authors:  Eun Ji Lee; Yu Ran Lee; Hee Kyoung Joo; Eun Jung Cho; Sunga Choi; Kyung-Cheol Sohn; Sang Do Lee; Jin Bong Park; Byeong Hwa Jeon
Journal:  Mol Cells       Date:  2013-04-29       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.